Respiratory syncytial virus is an “opportunistic” killer

Pediatric Pulmonology - Tập 53 Số 5 - Trang 664-667 - 2018
Mauricio T. Caballero1, Fernando P. Polack2,1
1Fundacion INFANT, Buenos Aires, Argentina
2Department of Pediatrics, Vanderbilt University, Nashville, Tennessee

Tóm tắt

AbstractRespiratory syncytial virus (RSV), responsible for more than three million yearly hospitalizations and up to 118 000 deaths in children under 5 years, is the leading pulmonary cause of death for this age group that lacks a licensed vaccine. Ninety‐nine percent of deaths due to the virus occur in developing countries. In‐hospital RSV fatalities affect previously healthy term infants in association with bacterial sepsis, clinically significant pneumothoraxes and, to a lesser extent, comorbid conditions. Community deaths affect low‐income children from socially vulnerable families and appear to be as frequent as inpatient fatalities. In industrialized countries, RSV deaths occur almost exclusively in children with premorbid conditions.In a sense, RSV is an “opportunistic” killer. It needs a synergistic premorbid, medical practice‐related, infectious, or social co‐factor to cause a fatal outcome. But while the complex problems associated with these co‐factors await solutions, candidate vaccines, long‐lived monoclonal antibodies and antivirals against RSV are under clinical evaluation. It seems reasonable to predict that the landscape of RSV infections will look different in the next decade.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(12)61728-0

The state of the world children 2008: child survival.https://www.unicef.org/sowc08/docs/sowc08.pdf.2008. Accessed October 10th 2017.

10.3201/eid2111.150497

10.1016/S0140-6736(05)71877-8

10.1016/S0140-6736(16)31593-8

10.1093/ije/dyq033

10.1186/s12879-014-0728-4

10.1016/S0140-6736(17)30938-8

10.1016/S2213-2600(16)30042-X

10.1001/jama.2010.675

10.7189/jogh.05.020419

10.1164/rccm.201301-0016OC

10.1164/rccm.201603-0658OC

10.1093/cid/cix740

10.1371/journal.pone.0053857

10.1093/infdis/jiu326

10.1542/peds.2014-2151

10.1016/S2214-109X(17)30344-3

10.1007/s40121-017-0160-3

10.1182/blood-2013-12-541359

10.1111/petr.12093

10.1002/ppul.23570

10.1183/09031936.00177111

10.1111/j.1440-1754.2008.01393.x

10.1097/00006454-200105000-00005

10.1203/01.PDR.0000127431.11750.D9

10.1016/S0140-6736(10)60206-1

10.7189/jogh.05.020416

10.1016/j.virol.2014.05.001

10.1126/science.1243283

10.1126/science.1234914

PATH. RSV vaccine and mAb snapshothttp://www.path.org/vaccineresources/details.php?i=1562. Accessed on 31st Ocober 2017.

10.1016/S2213-2600(15)00255-6

10.1056/NEJMoa1211917

10.1097/INF.0000000000001167

10.1371/journal.pone.0152015

10.1093/infdis/jix031

10.1056/NEJMoa1401184

10.1056/NEJMoa1413275

Thông tin
Thông tin xuất bản

Pediatric Pulmonology

Tập 53 Số 5

664-667

Thông tin tác giả